Chemistry Wealth Management’s Vanguard FTSE Developed Markets ETF VEA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5,385
Closed -$336K 210
2025
Q4
$336K Hold
5,385
0.06% 150
2025
Q3
$323K Hold
5,385
0.06% 156
2025
Q2
$307K Buy
5,385
+410
+8% +$22K 0.07% 149
2025
Q1
$253K Sell
4,975
-110
-2% -$5.57K 0.06% 154
2024
Q4
$243K Hold
5,085
0.06% 157
2024
Q3
$269K Buy
5,085
+298
+6% +$15.2K 0.06% 145
2024
Q2
$237K Buy
+4,787
New +$238K 0.06% 143
2023
Q3
Sell
-4,667
Closed -$216K 149
2023
Q2
$216K Buy
+4,667
New +$215K 0.07% 137
2022
Q1
Sell
-8,021
Closed -$410K 186
2021
Q4
$410K Buy
+8,021
New +$412K 0.34% 56

Other funds holding VEA

Chemistry Wealth Management's VEA Position: Q1 2026 in Review

Chemistry Wealth Management sold out of Vanguard FTSE Developed Markets ETF (VEA) in Q1 2026, closing a stake of 5,385 shares — an estimated $336K sold.

Chemistry Wealth Management first reported a position in VEA in Q4 2021 and held it in 9 quarters. The position peaked at $410K in Q4 2021. 2,894 funds tracked by Wall St. Rank hold VEA as of Q1 2026.

  • Chemistry Wealth Management reported no remaining Vanguard FTSE Developed Markets ETF position as of Q1 2026 after selling out during the quarter.
  • Chemistry Wealth Management sold 5,385 Vanguard FTSE Developed Markets ETF shares in Q1 2026, an estimated $336K.
  • Chemistry Wealth Management first reported a position in Vanguard FTSE Developed Markets ETF in Q4 2021 and held it in 9 quarters.
  • Chemistry Wealth Management's Vanguard FTSE Developed Markets ETF position peaked at $410K in Q4 2021.
  • 2,894 funds tracked by Wall St. Rank held Vanguard FTSE Developed Markets ETF as of Q1 2026.

Based on Chemistry Wealth Management's 13F filing for Q1 2026, filed 9 Apr 2026.